GGrantIndex
← Search

ASSESSING THE SAFETY OF CELL SUBSTRATES AND VACCINE COMPONENTS

$621,848N01FY2009AINIH

Ionis Pharmaceuticals, Inc., Carlsbad CA

Investigators

Abstract

The Assessing Safety of Cell Substrates and Vaccine Components contract characterizes new cell substrates and tests them for safety. Efforts to develop, characterize and validate assays for the detection of novel or latent/occult adventitious agents are also supported.

View original record on NIH RePORTER →
ASSESSING THE SAFETY OF CELL SUBSTRATES AND VACCINE COMPONENTS · GrantIndex